Immunovant (IMVT) Cash from Financing Activities (2019 - 2026)
Immunovant (IMVT) posted Cash from Financing Activities of $20.1 million for fiscal Q1 2027 (quarter ended Jun 30, 2026), up 588.7% from $2.92 million a year earlier and up 452.1% from the prior quarter.
Immunovant (IMVT) Cash from Financing Activities (2019 - 2026) Analysis & Trends
For the trailing twelve months through Jun 30, 2026, Cash from Financing Activities at Immunovant was $612.94 million, up 34.2% year-over-year; for FY2026 (ended Mar 31, 2026), it was $595.76 million, up 31.1% from FY2025.
- Annual Cash from Financing Activities shows a five-year compound annual growth rate of 9.2% (FY2021 to FY2026).
- In prior fiscal years, Immunovant's Cash from Financing Activities was $454.49 million in FY2025 (-3.8%), $472.43 million in FY2024 (+566.5%), $70.89 million in FY2023 (-64.6%) and $200.13 million in FY2022 (-47.8%).
- Quarterly Cash from Financing Activities has run from a low of $21,000 in fiscal Q1 2023 to a high of $564.6 million in fiscal Q3 2026 over five years.
- On a year-over-year basis, Cash from Financing Activities increased in three of the last five quarters, with growth averaging 221.7%.
- The strongest year-over-year quarter for Cash from Financing Activities in the past five years was fiscal Q1 2027, with growth of 588.7%; the weakest was fiscal Q3 2025, with a decline of 99.5%.
- According to Business Quant data, Cash from Financing Activities for the three prior fiscal quarters was $3.64 million (Q4 2026), $564.6 million (Q3 2026) and $24.6 million (Q2 2026).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Financing (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | -8.78 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | -5.05 Bn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | 1.76 Bn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | -2.02 Bn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | -47.00 Mn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | -1.48 Bn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | 2.34 Bn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | -3.66 Bn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | -426.70 Mn |
| 10 | Immunovant | 6.97 Bn | 6.97 Bn | - | 20.10 Mn |
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 20.10 Mn |
| Mar 31, 2026 | 3.64 Mn |
| Dec 31, 2025 | 564.60 Mn |
| Sep 30, 2025 | 24.60 Mn |
| Jun 30, 2025 | 2.92 Mn |
| Mar 31, 2025 | 450.61 Mn |
| Dec 31, 2024 | 2.46 Mn |
| Sep 30, 2024 | 730,000.00 |
| Jun 30, 2024 | 686,000.00 |
| Mar 31, 2024 | 1.55 Mn |
| Dec 31, 2023 | 469.84 Mn |
| Sep 30, 2023 | 148,000.00 |
| Jun 30, 2023 | 890,000.00 |
| Mar 31, 2023 | 233,000.00 |
| Dec 31, 2022 | 70.63 Mn |
| Jun 30, 2022 | 21,000.00 |
| Sep 30, 2021 | 200.04 Mn |
| Jun 30, 2021 | 91,000.00 |
| Mar 31, 2021 | 763,000.00 |
| Dec 31, 2020 | 446,000.00 |
Immunovant Cash from Financing Activities API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=cash-from-financing-activities&ticker=IMVT&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "cash-from-financing-activities", "ticker": "IMVT", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=cash-from-financing-activities&ticker=IMVT&period=max&api_key=YOUR_API_KEY");
const data = await res.json();